BeWeld Medical
Automating Manufacturing Processes of Implanted Devices
Company Overview
Snapshot
Founded in September 2021 by Asaf Gordon, BeWeld Medical operates with 1–10 employees. The company has raised $800,000 across two funding rounds, with MEDX Xelerator as an investor. In October 2022, BeWeld Medical, a MEDX Xelerator company, signed a strategic investment agreement.
Business overview
BeWeld Medical is developing technology for the automated manufacturing of medical grafts. The company's core technology focuses on industrial automation to streamline the production of implanted medical devices. It serves the healthcare and life sciences industries, specifically targeting the medical devices sector with a focus on medical treatment and therapeutics.
Strategic signal
In October 2022, BeWeld Medical, operating as a MEDX Xelerator company, signed a strategic investment agreement. This development signals external validation of its technology and business model, indicating potential for accelerated development and market entry for its automated medical graft manufacturing solutions.
Log in to access full profile ›Company Intelligence Q&A
- When was BeWeld Medical founded?
- BeWeld Medical was founded in September 2021.
- Who is the founder of BeWeld Medical?
- Asaf Gordon is the founder and CEO of BeWeld Medical.
- What is BeWeld Medical's primary focus?
- BeWeld Medical focuses on developing technology for the automated manufacturing of medical grafts, aiming to streamline the production of implanted medical devices.
- What was a significant corporate development for BeWeld Medical in late 2022?
- In October 2022, BeWeld Medical, a MEDX Xelerator company, signed a strategic investment agreement.
- Which investor participated in BeWeld Medical's November 2021 funding round?
- In November 2021, MEDX Xelerator invested in BeWeld Medical as part of a funding round.